Skip to Content

Join the 'Alpha-1 Proteinase Inhibitor Deficiency' group to help and get support from people like you.

Alpha-1 Proteinase Inhibitor Deficiency News

Related terms: Alpha-1 Antitrypsin Deficiency

Ted Koppel's Fight to Make COPD Headline News

Posted 7 Dec 2017 by Drugs.com

THURSDAY, Dec. 7, 2017 – The doctor who diagnosed Grace Anne Koppel with chronic obstructive pulmonary disease (COPD) didn't pull any punches. She should start getting her affairs in order, because she only had three to five years left due to her incurable lung disease. Expect to be hospitalized and on full-time oxygen support within a couple of years. "If you can think of a better way of ...

Health Tip: Understanding COPD

Posted 10 Nov 2017 by Drugs.com

-- Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death in the United States, affecting some 16 million Americans and potentially millions more who don't know they have it. According to the National Heart, Blood, and Lung Institute, COPD can make it difficult for people to breathe and harm their quality of life. In COPD, less air flows in and out of the lung's airways ...

Statins May Help People With COPD Live Longer

Posted 8 Sep 2017 by Drugs.com

FRIDAY, Sept. 8, 2017 – Drugs known as statins may have benefits beyond lowering "bad" LDL cholesterol levels. A new study suggests people with chronic lung disease who take these drugs may extend their survival. The study from Canada included nearly 40,000 people with chronic obstructive pulmonary disease (COPD). One in five patients was taking a statin, and those individuals had a 21 percent ...

Long-Acting Inhaler May Help in Early Stage COPD, Too

Posted 6 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 6, 2017 – The inhaler medication Spiriva (tiotropium bromide) may help slow the progression of COPD if given in the early stages of the disease, a new study suggests. Researchers found that the drug helped patients preserve more lung function over two years. It also cut down on symptom flare-ups and boosted patients' quality of life, on average. All of the study patients were in ...

Opioids a Threat to Seniors With COPD

Posted 6 Jul 2017 by Drugs.com

THURSDAY, July 6, 2017 – Seniors with COPD – a progressive lung disease that causes breathing problems – may increase their odds for heart-related death if they use opioid painkillers, a new study finds. COPD (chronic obstructive pulmonary disorder) patients are often prescribed opioids, including morphine and fentanyl. These narcotics can help treat chronic muscle and bone pain, insomnia, ...

FDA Allows Marketing of First Direct-to-Consumer Tests that Provide Genetic Risk Information for Certain Conditions

Posted 7 Apr 2017 by Drugs.com

April 6, 2017 – The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA that provide information on an individual’s genetic predisposition to certain medical diseases or conditions, which may help to make decisions about l ...

Can an Apple a Day Keep COPD Away?

Posted 23 Feb 2017 by Drugs.com

THURSDAY, Feb. 23, 2017 – Eating lots of fruits and vegetables is good for everyone – and may even help current and former smokers avoid chronic lung disease, a new investigation reveals. Apples, pears, green leafy vegetables and peppers appear to offer protection against COPD (chronic obstructive pulmonary disease), said researchers led by Joanna Kaluza, of the Warsaw University of Life ...

Oxygen Therapy Little Help for Those With Milder COPD

Posted 27 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 26, 2016 – A new study says that oxygen therapy may not help people in the less severe stages of chronic obstructive pulmonary disease (COPD). COPD is an umbrella term for the lung diseases chronic bronchitis and emphysema. The study findings could change clinical practice, the researchers added. In 2014, close to 16 million Americans said they'd been diagnosed with COPD, ...

When Indoor Temps Rise, So Do COPD Symptoms

Posted 2 Oct 2016 by Drugs.com

FRIDAY, Sept. 30, 2016 – High indoor temperatures can worsen symptoms of the lung disorder chronic obstructive pulmonary disease (COPD), particularly in homes with high levels of air pollution, researchers report. The research included 69 people with moderate to severe COPD. The disorder includes emphysema and chronic bronchitis. Symptoms include shortness of breath, coughing and wheezing. The ...

COPD Deaths Down for Most Americans: CDC

Posted 8 Sep 2016 by Drugs.com

THURSDAY, Sept. 8, 2016 – Fewer Americans are dying from chronic obstructive pulmonary disease (COPD), but not black women and the middle-aged, a new government report shows. Between 2000 and 2014, there was a 12 percent overall drop in deaths from the progressive lung disease, according to the U.S. Centers for Disease Control and Prevention. Report co-author Hanyu Ni said the figures aren't ...

Depression Plagues Many With COPD

Posted 17 Jun 2016 by Drugs.com

FRIDAY, June 17, 2016 – Struggling with chronic obstructive pulmonary disorder (COPD) may raise the risk of depression among patients with the incurable respiratory illness, two new studies suggest. One report, from scientists at Manchester Metropolitan University in England, found one in four patients with COPD suffered persistent depressive symptoms over the three years of the study. If ...

Kamada Wins FDA Approval for Glassia - a New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficiency

Posted 7 Jul 2010 by Drugs.com

NESS ZIONA, Israel--(BUSINESS WIRE)--Jul 6, 2010 - Kamada today announced that the United States Food and Drug Administration (FDA) has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin (AAT) for the treatment of Alpha 1 deficiency (AATD). Glassia is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- ...

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease

Related Drug Support Groups

Prolastin, Zemaira, alpha 1-proteinase inhibitor, Prolastin-C, Aralast, Aralast NP, Glassia